作者Mengyao Mu;Mengmeng Zhang;Yufang Gong;Kai Guo;Hui Liu;Zeran Zhang;Tongxin Jiang;Houren Zhou;Qing Fan;Dianlong Jia;Yuqin Li;Xiao Sun
（
1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China;2Institute of Pharmacology, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China;3These authors contributed equally to this work.;4Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China
）
出处
Chemical Engineering Journal 2024 Vol.502
P158139
摘要
Due to the large amount of PD-L1 on the surface of tumor cells, antibody drugs can only block a small part of PD-L1, limiting the effectiveness of imm
作者Mengyao Mu;Mengmeng Zhang;Yufang Gong;Kai Guo;Hui Liu;Zeran Zhang;Tongxin Jiang;Houren Zhou;Qing Fan;Dianlong Jia;Yuqin Li;Xiao Sun
（
1Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China;2Institute of Pharmacology, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China;3These authors contributed equally to this work.;4Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China
）
出处
Chemical Engineering Journal 2024
P158139
摘要
Due to the large amount of PD-L1 on the surface of tumor cells, antibody drugs can only block a small part of PD-L1, limiting the effectiveness of imm
